Quick Answer
Relay Therapeutics, Inc. reported Total Assets of $621.33 million for fiscal year 2025.
Relay Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $621.33M | -28.7% |
| 2024 | $871.30M | +3.2% |
| 2023 | $843.98M | -23.3% |
| 2022 | $1.10B | +9.1% |
| 2021 | $1.01B | +26.1% |
| 2020 | $799.83M | +103.5% |
| 2019 | $393.07M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $670.00M | -28.0% | -8.1% |
| June 30, 2025 | $728.84M | -5.7% | -8.8% |
| March 31, 2025 | $799.36M | -5.0% | -8.3% |
| December 31, 2024 | $871.30M | +3.2% | -6.3% |
| September 30, 2024 | $930.12M | +2.6% | +20.4% |
| June 30, 2024 | $772.55M | -19.7% | -8.2% |
| March 31, 2024 | $841.44M | -18.9% | -0.3% |
| December 31, 2023 | $843.98M | -23.3% | -6.9% |
- Relay Therapeutics, Inc. showed a decrease of -28.7% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Relay Therapeutics, Inc.’s total assets has grown by 58.1% (from $393.07 million to $621.33 million).
- The most recent figure is from Relay Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: